July 31, 2018 / 10:48 PM / 4 months ago

BRIEF-Laekna Acquires Exclusive Worldwide Rights To Two Clinical Stage Oncology Assets

July 31 (Reuters) - Laekna Inc-

* LAEKNA ACQUIRES EXCLUSIVE WORLDWIDE RIGHTS TO TWO CLINICAL STAGE ONCOLOGY ASSETS

* LAEKNA INC- SIGNED AGREEMENT WITH NOVARTIS PHARMA AG FOR EXCLUSIVE GLOBAL RIGHTS TO DEVELOP,COMMERCIALIZE TWO ORAL NOVARTIS CLINICAL-STAGE ONCOLOGY ASSETS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below